Candel Therapeutics Shares Are Trading Higher After the FDA Granted Orphan Drug Designation to CAN-3110.
Candel Therapeutics Shares Are Trading Higher After the FDA Granted Orphan Drug Designation to CAN-3110.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.